APC and Familial adenomatous polyposis: Familial adenomatous polyposis (FAP), neurofibromatosis type 1 (NF1), and Li-Fraumeni (LF) followed, with an estimated prevalence of 0.65% [5 APC, 5 NF1], and 0.39% [3 TP53].